The TGFR, which includes Lumitrace (relmapirazin), was approved on January 17th by the U.S. Food and Drug Administration (FDA). MediBeacon continues development of future TGFR products including a ...

Investigative journalist Lucie Morris-Marr was a fit and healthy 44-year-old mother of two when she received a shock diagnosis of invasive stage four bowel ...